04336899 · Active · incorporated 24 years, 11 months ago · Saffron Walden
Biotech B2B Biotech & Life Sciences Drug Discovery Series A
Provides preclinical drug discovery services, including molecular biology, biochemistry, and medicinal chemistry, to pharmaceutical and biotechnology companies.
Domainex Limited is a private limited company registered at Companies House under number 04336899, incorporated on 10 December 2001, with a registered office in Saffron Walden. Its current status on the register is active. Its filed nature of business covers research and experimental development on biotechnology (SIC 72110) and other research and experimental development on natural sciences and engineering (SIC 72190). Sonde has indexed 235 filings for this company, including 9 funding rounds. Its most recent round closed in June 2026, raising £1.3m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 9 | Jun 2026 | £1.3m | £15.00 |
| Round 8 | Jun 2023 | £31k | £1.47 |
| Round 7 | Apr 2021 | £27k | £2.47 |
| Round 6 | Oct 2018 | £33k | £2.47 |
| Round 5 | Nov 2017 | £654k | £25.00 |
| Round 4 | Feb 2014 | £879k | £25.00 |
Showing the 6 most recent of 9 rounds.
Domainex Limited has been offered £118k in grant funding across 1 Innovate UK project starting in 2018, mainly Feasibility Studies.
Source: Innovate UK funded projects (UKRI open data). Amounts are offers, not payments.
Showing the 12 most recent of 235 filings.
See the complete cap table with every shareholder, founder tags, dilution across 40 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.